Hemerion Therapeutics
Operator of a biotechnology platform intended to treat resistant tumors using proprietary photosensitizing molecules paired with advanced laser light technologies. The company offers a unique combinat...
Valuation
$0
Share Price
N/A
Total Raised
$14.2M
Last Round
N/A